From: Drug utilization and cost associated with inflammatory bowel disease management in Saudi Arabia
Medication | DDDa | Adm. Ra | Price (US Dollars) | Annual costd (US Dollars) |
---|---|---|---|---|
Biological agents | ||||
 Infliximab | 3.75 mg | Parenteral | 16.50 | 6023 |
 Adalimumab | 2.9 mg | Parenteral | 44.54 | 16,258 |
 Certolizumab | 14 mg | Parenteral | 37.98 | 13,865 |
 Golimumab | 1.66 mg | Parenteral | 21.99 | 8025 |
 Ustekinumab | 0.54 mg | Parenteral | 12.25 | 4470 |
 Vedolizumab | 5.4 mg | Parenteral | 45.84 | 16,730 |
Non-biological agents | ||||
 Azathioprine | 0.15 g | Oral | 0.69 | 254.64 |
 Mercaptopurine | 105 mgb | Oral | 1.12 | 408.8 |
 Methotrexate | 2.5 mg | Oral | 1.44 | 526.82 |
Parenteral | 0.24 | 87.41 | ||
 Sulfasalazine | 2 g | Oral | 0.30 | 110.37 |
 Mesalazine | 1.5 g | Oral | 1.16 | 425.69 |
Rectal | 2.67 | 976.98 | ||
 Prednisone | 10 mg | Oral | 0.04 | 16.06 |
 Prednisolone | 10 mg | Oral | 0.185 | 67.64 |
Parenteral | 0.52 | 189 | ||
 Hydrocortisone | 30 mg | Oral | 0.12 | 45.33 |
Parenteral | 0.65 | 237 | ||
 Budesonide | 9 mg | Oral | c | c |
 Metronidazole | 2 g | Oral | 0.37 | 138.21 |
1.5Â g | Parenteral | 6.51 | 2378.88 | |
 Ciprofloxacin | 1 g | Oral | 1.24 | 455.52 |
0.5Â g | Parenteral | 4.19 | 1529 |